Cytokinetics shares owned by Affinity Asset Advisors
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Affinity Asset Advisors
from 13F filings
Historical chart of Affinity Asset Advisors investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Affinity Asset Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $6.8M | 230k | 29.46 |
| 2023-06-30 | $4.1M | 125k | 32.62 |
| 2023-03-31 | $7.8M | 222k | 35.19 |
| 2022-12-31 | $4.0M | 88k | 45.82 |
| 2022-09-30 | $3.1M | 65k | 48.45 |
| 2022-06-30 | $589k | 15k | 39.27 |
| 2021-12-31 | $6.6M | 146k | 45.58 |
| 2021-09-30 | $4.5M | 125k | 35.74 |
| 2021-06-30 | $1.4M | 70k | 19.79 |
| 2021-03-31 | $930k | 40k | 23.25 |
| 2020-12-31 | $1.5M | 70k | 20.79 |